Beverly Hills Private Wealth’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$260K	Buy	+1,505	New	+$279K	0.04%	292
2025 Q4	–	Sell	-1,512	Closed	-$237K	–	339
2025 Q3	$237K	Sell	1,512 -216	-13%	-$34.3K	0.04%	301
2025 Q2	$262K	Sell	1,728 -185	-10%	-$24.7K	0.05%	289
2025 Q1	$288K	Buy	1,913 +59	+3%	+$9.89K	0.06%	278
2024 Q4	$342K	Sell	1,854 -181	-9%	-$34.9K	0.07%	231
2024 Q3	$401K	Sell	2,035 -332	-14%	-$69K	0.08%	217
2024 Q2	$489K	Sell	2,367 -26	-1%	-$5.89K	0.11%	190
2024 Q1	$648K	Buy	2,393 +202	+9%	+$48.2K	0.15%	154
2023 Q4	$518K	Sell	2,191 -417	-16%	-$82K	0.14%	161
2023 Q3	$511K	Sell	2,608 -2,276	-47%	-$467K	0.15%	143
2023 Q2	$1.01M	Buy	4,884 +2,885	+144%	+$574K	0.17%	136
2023 Q1	$403K	Buy	1,999 +331	+20%	+$75K	0.13%	182
2022 Q4	$363K	Buy	+1,668	New	+$364K	0.16%	142